NTRK2 and major depressive disorder: Edwards et al. demonstrated that a model PTP1B inhibitor (phosphatidic acid) was able to increase phosphorylation of TrkB (BDNF receptor in hippocampus), which restored correct neurogenesis and normalized the behavior of mice with MDD [102].